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Abstract The aim of the study is to assess QoL
depending on the choice of therapeutic regimen. From a
total of 200 patients, half (n = 100) were treated with
insulin (66% were females, age 52.1 ± 7.4—group A), the
remaining 100 received oral treatment (74% females, age
63.3 ± 8.3—group B). For self-assessment of QoL, the
WHOQOL-BREF questionnaire was used. In group A, we
found a negative inﬂuence of increased level of glycemia
and occurrence of coexisting diseases in the somatic
domain . In the psychological domain, frequent checkups
showed a positive inﬂuence while circulatory failure pro-
duced negative results. For social domain, disobeying of
recommended diet was strongly negative as well as
increased levels of glycemia and coexisting disease for
environmental domain. In group B, for somatic domain,
correct values of glycemia and place of residence had
positive inﬂuence. Incorrect values of BMI, WHR, and co-
existing disease inﬂuenced the same domain negatively. In
the psychological domain, a positive inﬂuence had place of
residence but a negative BMI, ischemic heart disease,
clinical complications. For environmental domain, a posi-
tive inﬂuence had correct values of glycemia but a negative
BMI, ischemic heart disease and clinical complications.
Finally, the social domain for group B was negatively
inﬂuenced by BMI, ischemic heart disease, clinical com-
plications, and lack of regular supervisions of glycemia
level. A higher assessment of quality of life was found in the
group of patients treated with oral hypoglycemic medicines
in somatic and environmental domains, and in the group of
patients treated with insulin in psychological domain.
Keywords Diabetes  QoL  Treatment
Introduction
Diabetes is a chronic disease, leading to many complica-
tions and, as a result, to disability. Recently, a signiﬁcant
increase in the incidence of diabetes, especially type 2, can
be observed. World Health Organization (WHO) antici-
pates that until 2025 the number of patients suffering from
diabetes will increase from 380 million in 2007 to 418
million by 2025. This prevalence is inﬂuenced by the
population aging, as well as changes in the way of living
lead to in an increase in body mass and a decrease in
physical activity [1].
Major clinical problems in diabetes include microangi-
opathies (nephropathy, retinopathy, and neuropathy) and
macroangiopathies (ischemic heart disease, stroke, and
diabetic foot). Diabetic patients with microvascular com-
plications show the strongest association between diabetes
and cardiomyopathy—an association that parallels the
duration and severity of hyperglycemia [2].
Co-existence of cardiovascular disease leads to a sig-
niﬁcant increase in clinical complications and thus to a
substantial decrease in the patients’ quality of life (QoL).
QoL of patients with diabetes is an important factor in
analyzing the effectiveness of medical and other care. It
results from a holistic need for approach to treatment and
necessity of monitoring in the ﬁeld of mental, physical, and
social functioning (Fig. 1).
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symptoms, patients also bear mental stress as well as
family, professional, social, and ﬁnancial costs. Therefore,
in diabetic patients there is a bigger risk of psychopatho-
logic disorders including depression [3, 4], anxiety [5, 6],
and nutritional disorders [7]. There are several available
publications concerning inﬂuence of the therapy on mor-
tality, patient’s satisfaction, and his/her biomedical
parameters, but only few publications concern inﬂuence of
therapy on QoL (Fig. 2).
Quality of life in relation to health status is a multidi-
mensional notion covering physical, psychological, and
social functioning which is affected by the disease and its
treatment. It can be seen as a subjective sense of life sat-
isfaction in basic ﬁelds of human functioning, i.e. physical
condition, mental state, family, and beyond family
relations, home, and life or professional activities, hobbies,
sexual activity, material, and living conditions as well as
spiritual/religious life [Text of the Constitution of The
World Health Organization. Off. Rec. WHO 1948]. Any
assessment of advantages and disadvantages of any therapy
should include evaluation of its impact on patient’s QoL
(Fig. 3).
The main goal of this study was to assess differences in
QoL depending on the type of treatment chosen for diabetic
type 2 patients (oral vs insulin). We also decided to analyze
the inﬂuence of socio-demographic and clinical factors on
quality of life measured by the World Health Organization
Quality of Life Assessment Instrument (WHOQOL-BREF)
form in the same group of patients (Fig. 4).
Fig. 1 Somatic domain
Fig. 2 Psychological domain
Fig. 3 Social domain
Fig. 4 Environmental domain
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123Methods
Two hundred patients suffering from type 2 diabetes
entered the study. Patients were assigned to two study
groups. The ﬁrst one consisted of insulin-treated patients
(group A), while the second of patients treated with an oral
hypoglycemic medication (group B). Group A patients had
their diabetes recognized at least 5 years prior to inclusion
and for at least two last years were on insulin. Also, group
B patients had at least a 5-year history of diabetes, but they
have never been insulin treated. All patients were included
during their hospitalization due to diabetes exacerbation.
Those who at the same time had an exacerbation of other
(concomitant) chronic diseases or for any reasons were not
able to participate and were excluded from the study. All
patients gave their informed consent; none of those invited
to participate refused.
TheresearchwasconductedattheDepartmentofInternal
Diseases and Allergology of the University Hospital in
Wroclaw between October, 2008, and March, 2009. Every
included patient was tested for the QoL in four domains:
psychological, somatic, social, and environmental with use
of general WHOQOL-BREF survey form. The WHO
QualityofLifeAssessment(WHOQOL)isagenericquality-
of-life instrument that has been designed to be applicable to
people living in different conditions or cultures. The
WHOQOL is based on the patients subjective assessment of
the perceived quality of life and in this way differs from
many other instruments. WHOQOL also approaches the
quality of life as a multidimensional concept. Further, it is
being suggested that the WHOQOL-BREF provides a valid
and reliable alternative to the assessment of domain proﬁles
withWHOQOL-100andisespeciallysensitivetothehealth-
related quality-of-life status of those with chronic diseases.
We have chosen the WHOQOL-BREF questionnaire
because it has been validated for the Polish population.
Further, the inﬂuence of independent variables on the
QoL has been analyzed in multiple regression analysis.
Predictors of quality of life considered in this study are the
following: social and demographic factors (age, sex, mar-
ital status, education, place of residence); clinical factors
(disease duration, physical activity, coexisting diseases,
BMI & WHR); and laboratory values (glycemia and total
cholesterol concentration in blood serum).
Physical activity was deﬁned according to the British
Regional Heart Study Questionnaire, on the basis of fre-
quency and intensity of physical exercise, which assigned
every patient to one of three groups: little active—less than
three walks or bicycle rides a week; moderately active—
walks or bicycle rides 3–4 times a week; highly active—
walks or bicycle rides more than 4 times a week. The
choice of the protocol resulted from the similarity of the
patients’ proﬁle.
STATISTICA 7.0 was used for statistical analysis. The
distribution type for all variables was determined. The
Shapiro–Wilk test was carried out. The critical level of
signiﬁcance was assumed at P\0.05. For measurable
(quantitative) variables, arithmetic means, standard devia-
tions, medians, as well as the range of variability
(extremes) were calculated, while for qualitative variables,
the frequency (percentage) was determined. The analysis of
qualitative variable was based on contingency tables and v
2
test. To compare quantitative variables in two non-related
and related groups, the Wilcoxon matched pairs test was
used, respectively. The Kruskal–Wallis test was conducted
for means of variables, which did not meet criteria of
variance analysis. Spearman rank correlation test was used
out to check the relations between variables (QoL vs.
clinical and laboratory factors). For each variable pair, the
Spearman’s rank correlation coefﬁcient was calculated, and
the level P\0.05 was assumed as statistically signiﬁcant.
Both answers to questions of the WHOQOL-BREF and
overall results did not have normal distribution, which was
conﬁrmed by the Shapiro–Wilk normality test. The impact
of socio-demographic factors, clinical indexes, and risk
factors on subjective evaluation of quality of life expressed
by the WHOQOL-BREF score was determined based on
the analysis of multiple regression.
Results
Group A consisted of 100 patients, including 66% of
women and 34% of men aged 25–78 (mean ± SD;
52.1 ± 7.4 years). Group B—n = 100; 74% of women
and 26% of men; aged 32–80 (63.3 ± 8.3 years).
(Chi
2 = 14.8186, P = 0.0006).
Patients in group A had a longer disease duration time.
In group A, 50% of respondents suffered from diabetes for
1–5 years, 34%—5–10 years, and 16%—more than
10 years. In the group B, 20% of respondents were in the
ﬁrst year of disease duration, 76%—1 and 5 years; 4%—
5–10 years (Chi
2 = 20.1491, P = 0.0002).
Diabetic complications distribution differed among the
two groups: retinopathies were diagnosed in 26% group A
patients vs. 16% in group B; nephropathies 8% in group A
and 5% in group B, neuropathies—4% in group A and 4%
in group B; (Chi
2 = 29.9745, P = 0.00001) The next
analyzed factor was the presence of coexisting diseases. In
group A, 84% of patients were also treated for arterial
hypertension vs. 70% in group B, 24 vs. 8%—for circu-
latory failure, 10 vs. 14%—for ischemic heart disease, and
30 vs. 44%—for rheumatic disease (Chi
2 = 3.268, ns).
Considering the available evidence, it seems that phys-
ical training (activity) can be an effective intervention
helping to control glycemia, comparable with planed
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123aerobic exercise [8]. For this reason, we looked at the
physical activity of patients from both groups. In group A,
30% were found a little active patients (vs. 26% in B
group); 54%—moderately active (vs. 66%); and 16%—
highly active (vs. 8%). Calculated BMI value in group A
was 28.63 ± 3.22 while in group B—26.73 ± 1.2, average
WHR values were (0.83 ± 0.09) and (0.86 ± 0.13)
(Chi
2 = 7.8395, P = 0.0051), respectively.
Comparative analysis of quality of life (WHOQOL-
BREF form) revealed some trends differentiating the both
studied groups; however, they have not reached statistical
signiﬁcance (Table 1).
Analyzing the impact of socio-demographic and clinical
factors on QoL of patients in group A, we found a negative
inﬂuence of increased level of glycemia (b = 0.43;
SD =- 5.35; P = 0.01) and occurrence of coexisting
diseases—particularly circulatory failure (b =- 0.39;
SD =- 6.63; P = 0.002) on QoL values in the somatic
domain. In the psychological domain, frequent checkups in
diabetic clinic showed a positive inﬂuence (b = 0.41;
SD = 4.67; P = 0.01), while circulatory failure produced
negative results (b =- 0.38; SD =- 8.22; P = 0.04). For
social domain disobeying of recommended diabetic diet
was strongly negative (b =- 0.37; SD =- 10.70;
P = 0.003), while for environmental domain increased
levels of glycemia (b =- 0.39; SD =- 6.93; P = 0.039)
and coexisting circulatory failure (b =- 0.40; SD =
-9.85; P = 0.029) were again negative. In group B, for
somatic domain, both correct values of glycemia
(b = 0.36; SD = 7.05; P = 0.0005) and the place of res-
idence (city) (b = 0.20; SD = 3.24; P = 0.036) had
positive inﬂuence. Incorrect values of BMI (b =- 0.49;
SD =- 3.27; P = 0.000004), WHR (b =- 0.21; SD =
-13.14; P = 0.04), coexisting ischemic heart disease
(b =- 0.33; SD =- 7.73; P = 0.0006) inﬂuenced the
same domain strongly negative. In the psychological
domain, a positive inﬂuence had the place of residence
(b = 0.24; SD = 4.61; P = 0.02), while a negative—
incorrect values of BMI (b =- 0.37; SD =- 2.94;
P = 0.0005), co-existing ischemic heart disease (b =
-0.40; SD =- 10.91; P = 0.0003), clinical complications
of diabetes (b =- 0.27; SD =- 5.30; P = 0.008) and
a long disease duration (b =- 0.29; SD =- 5.87;
P = 0.007). For environmental domain, a positive
inﬂuence had correct values of glycemia (b = 0.29;
SD = 7.63; P = 0.0002), whereas a negative—incorrect
values of BMI (b =- 0.51; SD =- 4.52; P = 0.00001),
co-existing ischemic heart disease (b =- 0.43; SD =
-13.36; P = 0.000003), and clinical complications of
diabetes (b =- 0.38; SD =- 8.24; P = 0.000009).
Finally, the social domain for group B patients was nega-
tively inﬂuenced by incorrect values of BMI (b =- 0.41;
SD =- 4.68; P = 0.001), co-existing ischemic heart dis-
ease (b =- 0.45; SD =- 17.8; P = 0.0001), clinical
complications of diabetes (b =- 0.27; SD =- 7.79;
P = 0.01), and lack of regular supervisions of glycemia
level (b =- 0.24; SD =- 3.52; P = 0.03), R
2 = 0.441.
Discussion
When designing our study to investigate QoL in diabetic
patients, we had taken into account determinants’ division
suggested by Rubin and Peyrot and had chosen two cate-
gories of determinants inﬂuencing QoL: socio-demo-
graphic (S-D) analysis and clinical variables. In our hands,
S-D results do not show any signiﬁcant inﬂuence on the
QoL what is similar to the report of Wa ¨ndell, who also
proves that age, sex, and education level are poor predic-
tors of QoL in diabetes [9]. There are data from other
studies showing that some S-D parameters (age, education)
correlate with QoL, however. For instance, Akinici dem-
onstrated a higher QoL of married people with a lower
educational level [10]. This may reﬂect the speciﬁcity of
QoL-measurement-tool used, which again underlines the
need to use only well-standardized and comparable
questionnaires.
Age and sex distribution if subjects enrolled in our
study were similar to those of the patients examined by
Chaveepojnkamjorn [11]. Other demographic parameters,
including city vs noncity resident status, were in concor-
dance with group presented by Papadopoulos [12]. We
failed, like several other investigators [13], to demonstrate
an inﬂuence of disease duration on the quality of life of
patients with diabetes. Most of our respondents have been
diagnosed with diabetes less than 5 years prior to the study
(group A:50%; group B: 76). This is consistent with Cha-
veepojnkamjorn study [11], while in Papadopoulos study
Table 1 Analysis of domains with WHOQOL-BREF survey in both treated groups
Group A Group B tP SD A SD B
Somatic 48.21429 48.94841 -0.362166 0.718544 7.83304 7.86834
Psychological 53.80556 53.19444 0.260331 0.795531 8.84813 9.32872
Social 52.22222 52.22222 0.000000 1.000000 14.50547 13.65512
Environment 47.90179 48.95833 -0.382797 0.703270 10.82541 10.55228
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123the dominant group suffered from diabetes for over
10 years [12].
We have demonstrated a signiﬁcant impact of both co-
existing diseases (arterial hypertension, rheumatic disease,
heart failure) and chronic complications of diabetes (sight
deterioration, kidney failure, chronic myalgia, diabetic
foot) on the QoL, similar to other investigators, such as
Lloyd [14] and Jacobson [13], while Wa ¨ndell [9] regards
angiopathies and resulting conditions as poor predictors of
the QoL [9].
While some studies looking into the relationship
between the level of diabetes control and the QoL report
low correlations, if any [15–18], in our research regular
checkups as well as patients awareness of correct levels of
glycemia correlated with the QoL, however. Also, over-
weight and obesity (BMI[25 and[30, respectively) have
been found both by us and other researchers [10]a s
important negative factors in determining the QoL.
Our QoL-WHOQOL-BREF-based-survey revealed a
higher QoL assessment in the psychological domain for
group A (insulin treatment), and a positive effects had
regular control visits while negative had coexisting dis-
eases (heart failure). Similar results were obtained by
Nadeau et al., and regular control of glucose concentration,
patient’s education, and regular visits to diabetologic clinic
correlated positively with the QoL [19]. In group B, the
low values in psychological domain were driven by high
BMI values, WHR, and co-existing diseases (particularly
ischemic heart disease), while positive trends were gener-
ated by the place of residence, reducing alcohol con-
sumption, but negative had BMI values, disease duration,
complications connected with diabetes and coexisting dis-
eases (ischemic heart disease).
To the contrary, a higher assessment in the somatic and
environmental domains for group B (oral treatment).
Similarly, Redekop [20] and Brown [21] presented a lower
QoL estimation by insulin-treated patients. In concordance
with this, Stewart et al. demonstrated that patients not
taking medication have higher QoL [22]. In patients
intensely treated, this can result from the possible side
effects of drugs as well as their inﬂuence on every day’s
schedule (especially for insulin treated). This also conﬁrms
a study where type 2 diabetes patients reported worsening
of QoL after treatment intensiﬁcation (adding of oral
agents or insulin) [23]. Social domain scored equally in
both of our study groups.
Interestingly enough, we noted a higher assessment of
QoL in all domains in women treated with insulin, while a
signiﬁcantly higher assessment of the QoL has been found
in men treated with oral medicines. But this observation
has to be further elucidated, and this research has to be
continued to conﬁrm. However, there are publications
proving that there is a negative impact of the female sex on
HRQoL, but the authors do not analyze the inﬂuence of
treatment regimens or other disease-related factors [24].
Since patient’s QoL assessment is an important measure
of a successful disease treatment, our study gives an
important tool in terms of doctors’ attitude to diabetic
patients depending on their sex, treatment regimen, co-
existing diseases, or place of habitation. Especially, the
QoL changes due to the treatment regimen seem to be
important, since they can be taken as an additional advice
for a physician choosing the regimen for the ﬁrst time.
Further research is needed, however, in order to precisely
determine the role of some other demographic data,
including education, disease duration, etc.
Conclusions
A higher assessment of quality of life was found in the
group of patients treated with oral hypoglycemic medicines
in somatic and environmental domains, and in the group of
patients treated with insulin in psychological domain. On
the assessment of the quality of life of patients with type 2
diabetes, in group A, a negative inﬂuence had co-morbidity
especially heart failure, increased values of glycemia, and
poor diabetes control, while a positive impact had a fre-
quent diabetes checkups in a diabetic clinic. In group B,
negative impact on the QoL had values of BMI & WHR as
well as co-morbidity—particularly ischemic heart disease,
occurrence of complications connected with diabetes and
lack of regular control visits. Positive impact had good
diabetes control.
Patients treated with insulin seem to be more stable as
far as the quality of life is concerned; they are less sus-
ceptible to most disease-related factors (co-morbidity,
overweight etc.) when compared to patients on oral
hypoglycemic drugs. Irrespective of the treatment regimen,
frequent checkups are an important positive factor for
diabetic patients.
In our opinion, this study increases the chance to indi-
vidualize doctors’ attitude to diabetic patients based on the
treatment they are on. Further study is needed to prepare
and assess such an individualized attitude in clinical
practice.
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